← All research areas

03 / RESEARCH AREAS

Measuring aging

Biological clocks, biomarkers and what it means to measure change.

QUESTIONS WE WANT TO UNDERSTAND

  1. What does a biological age estimate actually measure?

  2. Does a change in a marker predict a meaningful health outcome?

  3. How reproducible is a measurement across people and settings?

These questions describe the scope of this area. They are not findings or a list of active studies.

Research in this area

Newest published first

1–12 of 23 articles

Measuring aging

Does a Younger “Vascular Age” Mean Improved Vascular Structure?

Vascular readings can carry health information, but a lower predicted age, a changed arterial wall, and fewer future clinical events are separate results. We reanalyzed a public dataset of 36,223…

  • Cross-sectional age and algorithmsModerate
  • Pressure and mechanical conditionsStrong
  • Acute human tone and vessel sitesLimited
  • Clinical prognosisModerate
  • Management trial and surrogacyNot yet determinable
Lifestyle & function

Does daily regularity have independent value, or reflect activity and health?

Regularity can describe behavior beyond movement volume, but measurement, prognosis and intervention value are separate questions. In our NHANES reanalysis, RA retains a favorable mortality…

  • Measurement and finite identificationStrong
  • Conditional mortality associationsModerate
  • External prognostic evidenceModerate
  • Short interventions and physiologyLimited
  • Healthspan and clinical prescriptionsNot yet determinable
Lifestyle & function

At the same weight loss, does losing visceral fat offer greater benefits?

Weight alone does not describe fat distribution or metabolic change. Randomized lifestyle trials support different visceral fat reductions with different intervention bundles, even when average…

  • Randomized lifestyle bundles and fat distributionModerate
  • Long-term metabolic and diabetes associationsLimited
  • Fatty-acid/inflammatory pathways and selective removalLimited
  • Causal extra benefit at fixed weight lossNot yet determinable
  • Healthspan and routine imaging decisionsNot yet determinable
Mechanisms of aging

Protein accumulation in the aging brain: made locally or acquired from other cells?

Mouse experiments support the presence of neuron-derived protein material in microglia, with higher associated labeling signals in aged microglial samples. Some labeled proteins also disappear more…

  • Mouse cellular origin and recipient materialModerate
  • Effective persistence in selected brain regionsModerate
  • Routes, intrinsic rates and functional attributionLimited
  • Normal-human aging and intervention benefitNot yet determinable
Mechanisms of aging

Matrix fragments: drivers of aging, or echoes of tissue injury?

Elastin fragments can participate in immune signaling, and mouse interventions provide causal clues. Higher circulating concentrations can also reflect tissue injury, increased release or slower…

  • Circulating levels and originsLimited
  • Animal signaling mechanismsModerate
  • Naturally aged lifespanLimited
  • Specificity and safetyLimited
  • Human causality and healthspanNot yet determinable
Mechanisms of aging

Hepatic immune signals: new T cells, or expansion of existing cells?

A mouse study temporarily supplied three immune-support signals from the liver and improved some vaccine and antitumor responses in aged animals. Evidence for thymic involvement matters, but larger…

  • Thymus-related processesModerate
  • Repertoire depth and originsLimited
  • Animal function and withdrawalModerate
  • Model safetyLimited
  • Human protection and healthspanNot yet determinable
Mechanisms of aging

Why can aging muscle become more oxidative while function declines? Cardiolipin and compensation

An oxidative shift can compensate for mitochondrial damage without improving muscle function. A 2026 cardiolipin-depletion study demonstrates that separation: some muscles gain mitochondrial-content…

  • Measurements and denominatorsModerate
  • Depletion and cellular mechanismModerate
  • Animal function and recoveryLimited
  • Antioxidants and net effectsLimited
  • Human function and healthspanNot yet determinable
Mechanisms of aging

Longer lipids with age: a causal change or a shift in lipid composition?

These source tables show relative remodeling within lipid classes in some tissues, which cannot be explained entirely by replacement between classes. But “longer species become relatively favored,”…

  • Definitions and samplesModerate
  • Age/intervention remodelingModerate
  • Animal mechanism/lifespanLimited
  • Genetics and membrane physicsLimited
  • Human healthspan/applicationsNot yet determinable
The next frontiers

Can senolytic CAR T cells selectively remove harmful cells? Target choice and the cost of persistence

Anti-uPAR CAR T cells have produced functional benefits in mice, including improvements in some intestinal barrier, regeneration and inflammation measurements. Treatment early in life can also have…

  • Target and measurementModerate
  • Mouse functionModerate
  • Net value of persistenceNot yet determinable
  • Target-related injuryModerate
  • Human healthspanNot yet determinable
Mechanisms of aging

Why do senescent cells persist: target evasion or failure of immune clearance?

Persistent senescent cells can reflect changes in the target, immune cells and their shared environment. An October 2026 study connects chaperone-mediated autophagy (CMA) to all three: altered…

  • CMA and clearance measurementsModerate
  • Mechanisms between cellsModerate
  • Source tables and cell specificityLimited
  • Sustained clearance and feedbackNot yet determinable
  • Human applications and lifespanNot yet determinable
Mechanisms of aging

Why can STING inhibition help while deleting cGAS worsens aging?

Blocking STING and deleting cGAS are different interventions. The former can reduce some inflammatory signals; the latter removes both a DNA-sensing enzyme and its noncatalytic functions. Mouse and…

  • Interventions and multiple functionsModerate
  • Mouse functional benefitsModerate
  • Recorded lifespan and causalityLimited
  • Nuclear functions and inflammatory mediationLimited
  • Human applicationsNot yet determinable
Measuring aging

Which senescent cells are we actually identifying? Do different markers describe the same state?

Measurements can complement one another, but “p16-positive,” “p21-positive,” “high senescence-signature score” and “harmful cells worth clearing” remain different descriptions. Our analysis of a…

  • Detection definitionsModerate
  • Multimodal predictionLimited
  • External-study signature associationLimited
  • State and functional referencesModerate
  • Human clearance applicationsNot yet determinable

Search AgingScope

Explore AgingScope